WikiDoc.org

is a Free Up-to-Date Copyleft Medical Textbook With No Pharma or Device Support Viewed 896 Million x / yr updated by 7,000 contributors

[WikiDoc.org @wikidoc]

Our Legend...

[Radcliffe Cardiology @radcliffeCARDIO]

COMING SOON 🗓

What is Dr Mike Gibson’s advice to early career #cardiologists?

Tune in to a NEW episode of Parallax as host @AnkurKalraMD and @CMichaelGibson engage in a fascinating conversation on art, #medicine and fatherhood. 🎧

#Cardiotwitter #Medtwitter #Radcliffian

[Alberto Castro @acastrom91]

Another @wikidoc meeting where the dissemination of medical knowledge and global collaboration come together to build a true academic community. Honored to be part of a project founded by my mentor Dr. @CMichaelGibson that continues to impact medical education worldwide #MedEd

[MashupMD @MdMashup]

New insights from @CMichaelGibson: NEJM reviews pulmonary embolism treatments, newest data from multivessel PCI in AMI, and more! https://t.co/lBsZhP5mDK

[C. Michael Gibson MD @CMichaelGibson]

About to give grand rounds at Yale 😊

[C. Michael Gibson MD @CMichaelGibson]

Compared to DAPT using ticagrelor + aspirin, ticagrelor monotherapy beginning 1 month after PCI in pts with ACS undergoing PCI reduces clinically-relevant and major bleeding. Dr. @greggwstone and I discuss results of ULTIMATE-DAPT trial

[C. Michael Gibson MD @CMichaelGibson]

Selective aldose reductase inhibition with AT-001 no different than placebo in improving peak VO2 in diabetic cardiomyopathy. Dr. Januzzi and I discuss the results of the ARISE-HF study.

[C. Michael Gibson MD @CMichaelGibson]

BREAKING

Substantial amounts of high quality randomized clinical trial data demonstrate improved heart outcomes with intermittent fasting.

One of the world's experts in the area, Dr. Pam Taub, discusses the substantial shortcomings of observational nutritional data that the media are reporting on that are not consistent with previous high quality data.

Be skeptical of the study that the mainstream media is reporting on. Support studies that truly test the question.

[C. Michael Gibson MD @CMichaelGibson]

Point your camera at the QR bar code to be directed to the website to kick off MedStream 360 on April 18th at 7:30 EST.

[C. Michael Gibson MD @CMichaelGibson]

Today on @NBC10Boston Channel 810 at 4:00 PM and 5:30 PM @EliNBCBoston and I discuss the new CDC guidelines.

[C. Michael Gibson MD @CMichaelGibson]

.@payalkohlimd and I discuss Monkeypox #SnackableHealth

[C. Michael Gibson MD @CMichaelGibson]

CETP as a target of pharmacotherapy: An update with John Kastelein

[C. Michael Gibson MD @CMichaelGibson]

New bivalent vaccine from Moderna improves antibody response to booster

A conversation with Moderna CMO Paul Burton, M.D.

[C. Michael Gibson MD @CMichaelGibson]

.@payalkohlimd and I discuss listeria #SnackableHealth

[C. Michael Gibson MD @CMichaelGibson]

Mixing or matching mRNA #COVID19 booster provides similar outcomes in a network meta analysis

“a heterologous or a homologous third dose booster can confer an equal level of protection” https://t.co/xn1EdajMcx

[C. Michael Gibson MD @CMichaelGibson]

The Doctor Prescribed an Obesity Drug. Her Insurer Called It ‘Vanity.’

We must move beyond viewing obesity as a moral failing and the goal of being thin “vanity”

Obesity is a complex disease & treating it improves health outcomes https://t.co/ajKxIM0yFd

[ZOLL TherOx @ZOLLTherOx]

What defines a successful PCI outcome? Watch @CMichaelGibson and other experts discuss the challenges of #MVO post-PCI for #STEMI and how #SSO2 Therapy can have an impact. https://t.co/JseKn0sXWc

[Hannah Billig @Hannah_Billig_]

It‘s not too late for #sciencesunday 🔬🧬

Targeting cholesterol efflux after myocardial infarction could help to stabilize vulnerable plaques 🫀

👉 Review by @CMichaelGibson and colleagues, published in @JAHA_AHA
👉 Phase 3 clinical study, using human APO-I CSL112 on the way

[C. Michael Gibson MD @CMichaelGibson]

20% of the population may have a genetic abnormality in Lp(a) which is not treatable with statins or exercise

Giving an RNA silencing molecule #siRNASLN360 was well tolerated, & reduced Lp(a) in a dose dependent fashion (10% up to 98%).

https://t.co/XlrYPnBdrE

[C. Michael Gibson MD @CMichaelGibson]

Covid Pills that help reduce hospitalization to Become More Widely Available https://t.co/rUkVGx97ZH

[Baim Institute @BaimInstitute]

Digital technologies and the democratization of clinical research: Social media, wearables, and artificial intelligence
by Baim CEO @CMichaelGibson, and Baim faculty @skorjianmd
https://t.co/WLQkjPsNLR